Yan-Ruide Li

机构：University of California, Los Angeles, UCLA Health, MicroBio Engineering (United States), La Jolla Bioengineering Institute · ORCID：0000-0002-9858-300X

发表论文 79 篇 · 总被引 2261 次 · h-index 29

代表论文

• In vivo CAR engineering for immunotherapy (2025 · Nature reviews. Immunology · 被引 111)
• Emerging trends in clinical allogeneic CAR cell therapy (2025 · Med · 被引 51)
• Engineering the next generation of allogeneic CAR cells: iPSCs as a scalable and editable platform (2025 · Stem Cell Reports · 被引 25)
• Targeting triple-negative breast cancer using cord-blood CD34⁺ HSPC-derived mesothelin-specific CAR-NKT cells with potent antitumor activity (2025 · Journal of Hematology & Oncology · 被引 20)
• IL-18 revives dysfunctional CAR-T cells (2025 · Trends in cancer · 被引 18)
• Multimodal targeting of metastatic renal cell carcinoma via CD70-directed allogeneic CAR-NKT cells (2025 · Cell Reports Medicine · 被引 15)